Block M R, Lauquin G J, Vignais P V
Biochemistry. 1982 Oct 26;21(22):5451-7. doi: 10.1021/bi00265a011.
3'-O-(1-Naphthoyl)adenosine 5'-diphosphate (N-ADP), a fluorescent analogue of ADP, was established as a potent inhibitor of adenosine 5'-diphosphate/adenosine 5'-triphosphate (ADP/ATP) transport in mitochondria and inside-out sonic particles; the Ki value was about 5 microM. The inhibition was of a mixed type. On the other hand, N-ADP was not transported in a measurable way in either type of particles. Upon binding to the particles, the fluorescent intensity of N-ADP was decreased; the release of the bound N-ADP upon addition of carboxyatractyloside (CATR) to mitochondria and bongkrekic acid (BA) to sonic particles was reflected by increases of fluorescence. In parallel assays dealing with 14C-labeled N-ADP, specifically bound [14C]N-ADP was equated to [14C]N-ADP released upon addition of either CATR (mitochondria) or BA (sonic particles). The specific binding of N-ADP corresponded to 1.4-1.6 nmol/mg of protein in mitochondria, with a Kd value of 3 microM, and to 1.5-1.6 nmol/mg of protein in sonic particles, with a Kd value of 6 microM. Essentially similar values were obtained for N-ATP binding. These values are at least twice as high as those found for specific ADP or ATP binding, suggesting that N-ADP or N-ATP binds to potential nucleotide binding sites that were not totally occupied by ADP or ATP. Whereas nearly all the specifically bound N-ADP in mitochondria was displaced by an excess of ADP (400 microM) at pH 7.4, only 30% could be removed from sonic particles under the same conditions. Furthermore at pH 6.5, no more than half of the specifically bound N-ADP could be removed by excess ADP in mitochondria and only 10-20% in sonic particles. These results indicate that each ADP/ATP carrier unit contains at least two types of nucleotide sites capable of interacting with N-ADP. Because of the hydrophobic nature of the naphthoyl moiety of N-ADP, the data suggest that difference in N-ADP binding in mitochondria and sonic particles are related to differences in the hydrophobic nature of their sites. Due to the special features of N-ADP (strong specific binding to the ADP/ATP carrier and no competence for transport), this DP analogue was particularly suitable for investigating the sensitivity of the nucleotide binding sites of the carrier to chemical modifiers. Inactivation studies were therefore carried out with mitochondria and sonic particles to compare the sensitivity to UV light and butanedione of the binding of N-ADP, [3H]BA, and [14C]Ac-CATR, a radiolabeled substitute for CATR. Both in mitochondria and in sonic particles, UV light and butanedione inactivated more rapidly the binding of N-ADP than that of [3H]BA. On the other hand, in mitochondria, UV light inactivated more rapidly the binding of [14C]Ac-CATR than that of N-ADP; the reverse was true for the inactivation by butanedione. The inactivation data conclusively indicate that BA, CATR, and adenine nucleotides are recognized by different specific sets of amino acids.
3'-O-(1-萘甲酰基)腺苷5'-二磷酸(N-ADP)是ADP的一种荧光类似物,被证实是线粒体和外翻式超声破碎颗粒中腺苷5'-二磷酸/腺苷5'-三磷酸(ADP/ATP)转运的有效抑制剂;其Ki值约为5微摩尔。这种抑制作用属于混合型。另一方面,N-ADP在这两种颗粒中均未以可测量的方式进行转运。与颗粒结合后,N-ADP的荧光强度降低;向线粒体中加入羧基苍术苷(CATR)以及向外翻式超声破碎颗粒中加入硼酸曲菌素(BA)后,结合的N-ADP的释放表现为荧光增强。在涉及14C标记的N-ADP的平行实验中,特异性结合的[14C]N-ADP等同于加入CATR(线粒体)或BA(外翻式超声破碎颗粒)后释放的[14C]N-ADP。N-ADP的特异性结合在粒体中相当于1.4 - 1.6纳摩尔/毫克蛋白质,Kd值为3微摩尔;在外翻式超声破碎颗粒中相当于1.5 - 1.6纳摩尔/毫克蛋白质,Kd值为6微摩尔。N-ATP结合得到的数值基本相似。这些数值至少是特异性ADP或ATP结合数值的两倍,这表明N-ADP或N-ATP结合到了未被ADP或ATP完全占据的潜在核苷酸结合位点。在pH 7.4时,线粒体中几乎所有特异性结合的N-ADP都能被过量的ADP(400微摩尔)取代,但在相同条件下,外翻式超声破碎颗粒中只有30%的N-ADP能被去除。此外,在pH 6.5时,线粒体中过量的ADP最多只能去除一半特异性结合的N-ADP,而外翻式超声破碎颗粒中只能去除10 - 20%。这些结果表明,每个ADP/ATP载体单元至少包含两种能够与N-ADP相互作用的核苷酸位点。由于N-ADP的萘甲酰基部分具有疏水性,数据表明线粒体和外翻式超声破碎颗粒中N-ADP结合的差异与其位点疏水性的差异有关。由于N-ADP的特殊性质(与ADP/ATP载体有强特异性结合且无转运能力),这种二磷酸类似物特别适合用于研究载体核苷酸结合位点对化学修饰剂的敏感性。因此,利用线粒体和外翻式超声破碎颗粒进行了失活研究,以比较N-ADP、[3H]BA和[14C]Ac-CATR(一种CATR的放射性标记替代物)结合对紫外线和丁二酮的敏感性。在线粒体和外翻式超声破碎颗粒中,紫外线和丁二酮使N-ADP结合失活的速度都比[3H]BA快。另一方面,在线粒体中,紫外线使[14C]Ac-CATR结合失活的速度比N-ADP快;而丁二酮失活的情况则相反。失活数据确凿地表明,BA、CATR和腺嘌呤核苷酸是由不同的特定氨基酸组识别的。